{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:22:36Z","timestamp":1790680956915,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2011,5,1]]},"DOI":"10.1002\/emmm.201100130","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T09:52:34Z","timestamp":1297936354000},"page":"249-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Pml represses tumour progression through inhibition of mTOR"],"prefix":"10.1038","volume":"3","author":[{"given":"Rosa","family":"Bernardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Papa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainara","family":"Egia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Coltella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Teruya\u2010Feldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Signoretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pandolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"BFEMMM201100130_CR1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nature05029","volume":"442","author":"R Bernardi","year":"2006","unstructured":"Bernardi R, Guernah I, Jin D, Grisendi S, Alimonti A, Teruya\u2010Feldstein J, Cordon\u2010Cardo C, Simon MC, Rafii S, Pandolfi PP (2006) PML inhibits HIF\u20101alpha translation and neoangiogenesis through repression of mTOR. Nature 442: 779\u2010785","journal-title":"Nature"},{"key":"BFEMMM201100130_CR2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","volume":"12","author":"PT Bhaskar","year":"2007","unstructured":"Bhaskar PT, Hay N (2007) The two TORCs and Akt. Dev Cell 12: 487\u2010502","journal-title":"Dev Cell"},{"key":"BFEMMM201100130_CR3","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/hmg\/ddp149","volume":"18","author":"CS Bonnet","year":"2009","unstructured":"Bonnet CS, Aldred M, von Ruhland C, Harris R, Sandford R, Cheadle JP (2009) Defects in cell polarity underlie TSC and ADPKD\u2010associated cystogenesis. Hum Mol Genet 18: 2166\u20102176","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201100130_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000478-200103000-00001","volume":"25","author":"M de Peralta\u2010Venturina","year":"2001","unstructured":"de Peralta\u2010Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25: 275\u2010284","journal-title":"Am J Surg Pathol"},{"key":"BFEMMM201100130_CR5","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/hmg\/3.10.1833","volume":"3","author":"AJ Green","year":"1994","unstructured":"Green AJ, Johnson PH, Yates JR (1994) The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 3: 1833\u20101834","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201100130_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","volume":"30","author":"LS Harrington","year":"2005","unstructured":"Harrington LS, Findlay GM, Lamb RF (2005) Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 30: 35\u201042","journal-title":"Trends Biochem Sci"},{"key":"BFEMMM201100130_CR7","first-page":"400","volume":"59","author":"EP Henske","year":"1996","unstructured":"Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ (1996) Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet 59: 400\u2010406","journal-title":"Am J Hum Genet"},{"key":"BFEMMM201100130_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST0370217","volume":"37","author":"J Huang","year":"2009","unstructured":"Huang J, Manning BD (2009) A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem Soc Trans 37: 217\u2010222","journal-title":"Biochem Soc Trans"},{"key":"BFEMMM201100130_CR9","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/0008-5472.CAN-09-0975","volume":"69","author":"J Huang","year":"2009","unstructured":"Huang J, Wu S, Wu CL, Manning BD (2009) Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Res 69: 6107\u20106114","journal-title":"Cancer Res"},{"key":"BFEMMM201100130_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","volume":"57","author":"H Kenerson","year":"2005","unstructured":"Kenerson H, Dundon TA, Yeung RS (2005) Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 57: 67\u201075","journal-title":"Pediatr Res"},{"key":"BFEMMM201100130_CR11","first-page":"1206","volume":"59","author":"T Kobayashi","year":"1999","unstructured":"Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T (1999) Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ\u2010line Tsc2 mutation in mice. Cancer Res 59: 1206\u20101211","journal-title":"Cancer Res"},{"key":"BFEMMM201100130_CR12","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1038\/onc.2010.393","volume":"29","author":"MD Lacher","year":"2010","unstructured":"Lacher MD, Pincheira R, Zhu Z, Camoretti\u2010Mercado B, Matli M, Warren RS, Castro AF (2010) Rheb activates AMPK and reduces p27Kip1 levels in Tsc2\u2010null cells via mTORC1\u2010independent mechanisms: implications for cell proliferation and tumorigenesis. Oncogene 29: 6543\u20106556","journal-title":"Oncogene"},{"key":"BFEMMM201100130_CR13","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.1314405","volume":"19","author":"L Ma","year":"2005","unstructured":"Ma L, Teruya\u2010Feldstein J, Behrendt N, Chen Z, Noda T, Hino O, Cordon\u2010Cardo C, Pandolfi PP (2005) Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppression. Genes Dev 19: 1779\u20101786","journal-title":"Genes Dev"},{"key":"BFEMMM201100130_CR14","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","volume":"19","author":"BD Manning","year":"2005","unstructured":"Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC (2005) Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes Dev 19: 1773\u20101778","journal-title":"Genes Dev"},{"key":"BFEMMM201100130_CR15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","volume":"104","author":"H Onda","year":"1999","unstructured":"Onda H, Lueck A, Marks PW, Warren HB, Kwiatkowski DJ (1999) Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104: 687\u2010695","journal-title":"J Clin Invest"},{"key":"BFEMMM201100130_CR16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-8-38","volume":"8","author":"K Pollizzi","year":"2009","unstructured":"Pollizzi K, Malinowska\u2010Kolodziej I, Stumm M, Lane H, Kwiatkowski D (2009) Equivalent benefit of mTORC1 blockade and combined PI3K\u2010mTOR blockade in a mouse model of tuberous sclerosis. Mol Cancer 8: 38","journal-title":"Mol Cancer"},{"key":"BFEMMM201100130_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BST0370259","volume":"37","author":"JR Sampson","year":"2009","unstructured":"Sampson JR (2009) Therapeutic targeting of mTOR in tuberous sclerosis. Biochem Soc Trans 37: 259\u2010264","journal-title":"Biochem Soc Trans"},{"key":"BFEMMM201100130_CR18","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1038\/onc.2008.283","volume":"27","author":"M Shiono","year":"2008","unstructured":"Shiono M, Kobayashi T, Takahashi R, Sun G, Abe M, Zhang D, Wang L, Piao X, Takagi Y, Mineki R, et al (2008) The G1556S\u2010type tuberin variant suppresses tumor formation in tuberous sclerosis 2 mutant (Eker) rats despite its deficiency in mTOR inhibition. Oncogene 27: 6690\u20106697","journal-title":"Oncogene"},{"key":"BFEMMM201100130_CR19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature04809","volume":"441","author":"LC Trotman","year":"2006","unstructured":"Trotman LC, Alimonti A, Scaglioni PP, Koutcher JA, Cordon\u2010Cardo C, Pandolfi PP (2006) Identification of a tumour suppressor network opposing nuclear Akt function. Nature 441: 523\u2010527","journal-title":"Nature"},{"key":"BFEMMM201100130_CR20","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/hmg\/ddi190","volume":"14","author":"C Wilson","year":"2005","unstructured":"Wilson C, Idziaszczyk S, Parry L, Guy C, Griffiths DF, Lazda E, Bayne RA, Smith AJ, Sampson JR, Cheadle JP (2005) A mouse model of tuberous sclerosis 1 showing background specific early post\u2010natal mortality and metastatic renal cell carcinoma. Hum Mol Genet 14: 1839\u20101850","journal-title":"Hum Mol Genet"},{"key":"BFEMMM201100130_CR21","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1158\/0008-5472.CAN-06-1740","volume":"66","author":"C Wilson","year":"2006","unstructured":"Wilson C, Bonnet C, Guy C, Idziaszczyk S, Colley J, Humphreys V, Maynard J, Sampson JR, Cheadle JP (2006) Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+\/\u2212 mice. Cancer Res 66: 7934\u20107938","journal-title":"Cancer Res"},{"key":"BFEMMM201100130_CR22","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1093\/hmg\/ddp398","volume":"18","author":"J Zhou","year":"2009","unstructured":"Zhou J, Brugarolas J, Parada LF (2009) Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. Hum Mol Genet 18: 4428\u20104441","journal-title":"Hum Mol Genet"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201100130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emmm.201100130","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1002\/emmm.201100130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.1002\/emmm.201100130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1002\/emmm.201100130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:59:20Z","timestamp":1779083960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1002\/emmm.201100130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5,1]]}},"alternative-id":["BFEMMM201100130"],"URL":"https:\/\/doi.org\/10.1002\/emmm.201100130","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]},"assertion":[{"value":"1 April 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}